Alivus Life Sciences (ALIVUS) Rating, Buy/Sell, Forecast, Analysis

Details

Name	Symbol	Sector
ALIVUS LIFE SCIENCES LIMITED	ALIVUS	Pharmaceuticals

Open

959

High

968.4

Low

933.3

Close

944.1

Volume

60684

Exchange

nse

Time

14/08

Outlook

Score: 1.75
Rating: RISKY

Candlestick Pattern

Candle pattern of Alivus Life Sciences is None
Estimated Stoploss of Alivus Life Sciences is ₹ 968.4
Alivus Life Sciences has a Bearish pattern.
Formation of None candle pattern indicates the trend direction of Alivus Life Sciences is Unpredictable .

Trend

Alivus Life Sciences is in Downtrend .
Price of Alivus Life Sciences is Down by 6.18 %.

Target

Buy @ 925.8
Sell @ 1011

Volume

The trade volumes of Alivus Life Sciences have become Deficient
The volume trend for Alivus Life Sciences is Bearish , but the participants are Weak Sellers
The trade volume of Alivus Life Sciences is Down by 33.74 %

Valuation

The current market price of Alivus Life Sciences is Undervalued

Financials

Balance
The balance sheet of Alivus Life Sciences is: Balanced

Cashflow
Alivus Life Sciences has Poor cash flow because there is Shortage of ₹ 230cr . It is Down by 1452.94 %. (*Mar 2025) 38.64% i.e. ₹ 391cr earned in operating 60.77% i.e. ₹ 615cr spent in investing 0.59% i.e. ₹ 6cr spent in financing 0% in other
Alivus Life Sciences has Maintained cash flow because there is Surplus of ₹ 17cr . It is Up by 107.46 %. (*Mar 2024) 51.11% i.e. ₹ 413cr earned in operating 14.36% i.e. ₹ 116cr spent in investing 34.53% i.e. ₹ 279cr spent in financing 0% in other

Income
The income of Alivus Life Sciences is ₹ 610cr and Profit is : ₹ 121cr (Jun 2025) Alivus Life Sciences Profit is down by: 14.18 % and Income is Down by: 7.44 % (Jun 2025)
The income of Alivus Life Sciences is ₹ 659cr and Profit is : ₹ 141cr (Mar 2025) Alivus Life Sciences Profit is up by: 3.68 % and Income is Up by: 1.07 % (Mar 2025)
The income of Alivus Life Sciences is ₹ 652cr and Profit is : ₹ 136cr (Dec 2024) Alivus Life Sciences Profit is up by: 43.16 % and Income is Up by: 26.6 % (Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.